December 06, 2018

Bayer puts the brakes on vilaprisan trials following safety concerns

The decision to halt trials for the uterine fibroid product marks another setback in an area where there are few suitable solutions for patients.

October 19, 2018

Abbvie makes a big bet on preclinical integrin inhibitors

October 04, 2017

Therapy focus – No safe haven for bio in spinocerebellar ataxia

May 19, 2015

Dry eye development reaches the Eleventh hour

April 23, 2015

GSK labours the point of addressing the unloved unmet needs

August 06, 2014

Waiting game continues with Mircera launch

January 03, 2014

Pharma business development news over Christmas

March 05, 2013

Lexicon could define Sanofi as the ideal diabetes partner

April 13, 2012

Therapeutic focus - Amgen buys novel kidney disease treatment as bundling bites